Jimenez Freddy A.'s Form 4 filing
Celldex Therapeutics, Inc. (CLDX) · filed Aug 15, 2025
- Accession no.
- 0001415889-25-022069
- Filed
- Aug 15, 2025
- Trade date
- Aug 13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $19.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jimenez Freddy A.CIK 0001838114 | Officer (SVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | Common Stock | SSaleDisposed | −341 | $23.95 | −$8,166.95 | 35,392 | Direct | |
| Aug 13, 2025 | Common Stock | SSaleDisposed | −430 | $25.42 | −$10,930.6 | 34,962 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.